Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | GFER | P55789 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.41 |
| ▸ | MMP2 | P08253 | 2/20 | 0.40 |
| ▸ | MMP9 | P14780 | 2/20 | 0.40 |
| ▸ | MMP12 | P39900 | 2/20 | 0.40 |
| ▸ | MMP1 | P03956 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5526503 | 0.84 | ELANE (0.32) | — | |
| SCHEMBL44289 | 0.83 | MAPT (0.33) | HSD17B10SRD5A2POLBMAPTLMNA | |
| Ethylene Glycol SCHEMBL4451270 | 0.81 | MAPT (0.31) | SRD5A2MAPTLMNA | |
| SCHEMBL14690221 | 0.81 | MAPT (0.32) | POLBMAPTLMNA | |
| SCHEMBL6945031 | 0.80 | MMP1 (0.46) | KMT2AMEN1HTTMMP2MMP9 | |
| SCHEMBL8693868 | 0.79 | MAPT (0.49) | SRD5A2MAPK1L3MBTL1SLC6A2SLC6A3 | |
| SCHEMBL3310042 | 0.79 | ALDH1A1 (0.54) | KMT2AHTTMMP2MMP9MMP12 | |
| SCHEMBL30855603 | 0.79 | ALDH1A1 (0.54) | KMT2AHTTMMP2MMP9MMP12 | |
| SCHEMBL44290 | 0.79 | LMNA (0.35) | KMT2AMEN1HTTSRD5A2POLB | |
| SCHEMBL7565875 | 0.79 | ELANE (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1170287-B1 | PROCESS FOR PREPARATION OF OPTICALLY ACTIVE N-SUBSTITUTED AZETIDINE-2-CARBOXYLIC ACIDS | KANEKA CORP (JP) | 2003-12-03 | — | — | EP | disclosed |
| US-6617461-B2 | Cyclizing an optically active 4-substituted amino-2-halobutyric acid containing substituted oxycarbonyl or sulfonyl type protective group in presence of a base | KANEKA CORPORATION (JP) | 2003-09-09 | — | — | US | disclosed |
| US-20030045730-A1 | Process for preparation of optically active n-substituted azetidine-2-carboxylic acids | KANEKA CORPORATION (JP) | 2003-03-06 | — | — | US | disclosed |
| EP-1170287-A1 | PROCESS FOR PREPARATION OF OPTICALLY ACTIVE N-SUBSTITUTED AZETIDINE-2-CARBOXYLIC ACIDS | KANEKA CORPORATION (JP) | 2002-01-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030045730-A1 | Process for preparation of optically active n-substituted azetidine-2-carboxylic acids | NISCH, ADCY9, ALAD | KMT2A 2398/4885MEN1 3225/4885HTT 963/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.